Yasser Alotaibi¹, Maha Bassim², Noura Alnowaiser³, Mohamed Nassif⁴, Amal Al-Gosi⁵ and Mostafa Kofi⁵*

¹Family Physician, Continuous Quality Improvement and Patient Safety, Medical Services General Directorate, Riyadh, Kingdom of Saudi Arabia
²Consultant and Senior Trainer in Family Medicine, Medical Doctorate degree in Family Medicine, Department of Family and Community Medicine at PSMMC, Riyadh, Kingdom of Saudi Arabia
³Director of Continuous Quality Improvement and Patient Safety Department, Director SMO At Health Services General Directorate, Ministry of Defense, Senior Consultant Family Medicine, Member of Executive Committee for Saudi Center of Accreditation for Healthcare Institutions (CBAHI), Member of Board of Directors for Saudi Patient Safety Center, International JCI Consultant, Kingdom of Saudi Arabia
⁴Physician with Master Degree in Healthcare Quality, Public Health, Ain Shams University, Egypt and Master Degree in Business Administration, Edinburgh School of Business, Heriot Watt University, Scotland and NAHQ Certified Professional in Healthcare Quality CPHQ, NPSF/IHI Certified Professional in-patient Safety CPPS and Lean Six Sigma Green Belt, Currently Working as Healthcare Quality Expert in Health Services Directorate of Ministry of Defense in Saudi Arabia, Kingdom of Saudi Arabia
⁵Consultant, Family and Community Medicine Department, Prince Sultan Military Medical City, Riyadh, Kingdom of Saudi Arabia

*Corresponding Author: Mostafa Kofi Consultant, Family and Community Medicine Department, Prince Sultan Military Medical City, Riyadh, Kingdom of Saudi Arabia.

Received: October 18, 2021; Published: November 17, 2021

Abstract

Introduction: VTE is a common preventable complication for hospital bed stay and responsible for a huge loss in costs and deaths. Despite the MDS required target of 95% for compliance to the implementation of VTE thrombo-prophylaxis; unfortunately; the current status is not the case.

Methods: The Institute for Health Care Improvement (IHI) model of health care improvement was used. Pre-post implementation of VTE prophylaxis program was implemented in 2020 compared to 2017 at Medical Services Department (MSD) hospitals comparison of KPI before and after was analyzed using descriptive and analytic statistics.

Results: The average compliance for VTE prophylaxis in 21 MSD hospitals was 80% in the second quarter 2017 with 5 hospitals performing below 80% two of them performed below 40%. Also, Increase the compliance to the VTE prophylaxis in MSD Hospitals, to reach the target 95% within 12 months. Study of different interventions strategies effectiveness used by the hospitals for improving the use of VTE prophylaxis; led to improve compliance with CIBHI standard.

Conclusion: The quality improvement project for 5 MSD hospitals, showed a statistically significant difference for improvement after implementing VTE prophylaxis improvement program from 70% to 99% during the project study duration.

For the desired outcomes, the intervention strategies have to be strong and multilayered such as, implementing VTE prophylaxis policy, Leadership involvement, linking VTE prophylaxis compliance to the annual physician evaluation, frequent auditing, personal feedback, training and education

Keywords: VTE; Health Care Research; Quality Improvement

References

1. Stone J., et al. “Deep vein thrombosis: pathogenesis, diagnosis, and medical management”. Cardiovascular Diagnosis and Therapy 7 (2017): S276-S284.
2. Spyropoulos AC., et al. “The use of weighted and scored risk assessment models for venous thromboembolism”. Thrombosis and Haemostasis 6 (2012): 1072-1076.
3. Collins R., et al. “Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery”. The New England Journal of Medicine 18 (1988): 1162-1173.
4. The Breakthrough Series. “IHI’s Collaborative Model for Achieving Breakthrough Improvement”. Institute for healthcare improvement (2020).
5. “Revised Standards for Quality Improvement Reporting Excellence (SQUIRE 2.0)”. September 15, 2015. Revised Standards for Quality Improvement Reporting Excellence (2015).
6. The National Patient Safety Foundation. Second online publication, Version 2, January 2016, RCA2 Improving Root Cause Analyses and Actions to Prevent Harm (2016).
7. Internet Citation: Chapter 5. Implement the VTE Prevention Protocol. Content last reviewed February 2016. Agency for Healthcare Research and Quality, Rockville, MD (2013).
8. Alice G Bateman., et al. “The implementation of nice guidance on venous thromboembolism risk assessment and prophylaxis: a before-after observational study to assess the impact on patient safety across four hospitals in England”. BMC Health Services Research203 (2013).
9. Alexander T Cohen., et al. “Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial”. BMJ 7537 (2006): 325-329.
10. Walter Ageno and Beverley J Hunt. “Reducing the burden of venous thromboembolism in the acute medically ill population with extended-duration thromboprophylaxis”. The New England Journal of Medicine 23 (2011): 2167-2177.
11. Alina Wilkowska., et al. “Risk and prophylaxis of venous thromboembolism in hospitalized psychiatric patients. A review”. Psychiatria Polska3 (2018): 421-435.

Citation

Citation: Mostafa Kofi., et al. “Improving the Compliance to the Use of Venous Thromboembolism (VTE) Prophylaxis in Medical Services Department Hospitals, Riyadh, Saudi Arabia”.Acta Scientific Medical Sciences 5.12 (2021): 104-111.

Copyright

Copyright: © 2021 Mostafa Kofi., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.